The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...

By exiting the WHO and pulling funding, the U.S. would lose any leverage to enact those reforms,” writes Ashish K. Jha.

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

Mango was instrumental to the effort to develop Covid-19 vaccines and treatments, and was working on the Trump transition ...

For the first time, the Alcohol and Tobacco Tax and Trade Bureau proposed rules that would bring alcohol labels closer in ...

In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

The FTC announced Friday it reached a settlement with Welsh Carson that limits the private equity firm’s involvement in its ...

What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...

Tens of billions of dollars in hospital revenue could be at stake if Medicare cuts payments for outpatient care.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...